메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Jihye Kim (Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine) Wonseok Kang (Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine) Dong Hyun Sinn (Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine) Geum-Youn Gwak (Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine) Yong-Han Paik (Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine) Moon Seok Choi (Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine) Joon Hyeok Lee (Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine) Kwang Cheol Koh (Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine) Seung Woon Paik (Department of Medicine Samsung Medical Center Sungkyunkwan University School of Medicine)
저널정보
대한간학회 Clinical and Molecular Hepatology Clinical and Molecular Hepatology 제26권 제4호
발행연도
2020.1
수록면
516 - 528 (13page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background/Aims: Although hepatocellular carcinoma (HCC) is notorious for its high recurrence rate, some patients do not experience recurrence for more than 5 years after resection or radiofrequency ablation for early-stage HCC. For those with five recurrence-free period, the risk of HCC recurrence within the next 5 years remains unknown. Methods: A total of 1,451 consecutive patients (median, 55 years old; males, 79.0%; hepatitis B virus-related, 79.3%) with good liver function (Child-Pugh class A) diagnosed with early-stage HCC by Barcelona Clinic Liver Cancer Staging and received radiofrequency ablation or resection as an initial treatment between 2005 and 2010 were analyzed. Results: During a median follow-up period of 8.1 years, 961 patients (66.2%) experienced HCC recurrence. The cumulative recurrence rates increased to 39.7%, 60.3%, and 71.0% at 2, 5, and 10 years, respectively, and did not reach a plateau. Five years after HCC diagnosis, 487 patients were alive without experiencing a recurrence. Among them, during a median of 3.9 additional years of follow-up (range, 0.1?9.0 years), 127 patients (26.1%) experienced recurrence. The next 5-year cumulative recurrence rate (5?10 years from initial diagnosis) was 27.0%. Male sex, higher fibrosis-4 scores, and alpha-fetoprotein levels at 5 years were associated with later HCC recurrence among patients who did not experience recurrence for more than 5 years. Conclusions: The HCC recurrence rate following 5 recurrence-free years after HCC treatment was high, indicating that HCC patients warrant continued HCC surveillance, even after 5 recurrence-free years.

목차

등록된 정보가 없습니다.

참고문헌 (49)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0